Multistate Investigation of Suspected Infections Following Steroid Injections
Posted May 30, 2013 5:30 PM ET
This website will be updated on Mondays and Thursdays by 2pm ET.
At a Glance:
Status: On-going Investigation
Reported Cases: 20 *
States reporting cases: 3
Recall: Yes
Initial Announcement
May 30, 2013
Main Street Family Pharmacy in Tennessee: FDA Alerts Health Care Providers of Adverse Reactions Associated with Steroid Injections
State, Federal Health Officials Investigate Reports of Adverse Events among Patients Receiving Methylprednisolone Acetate Injections
Summary of Investigation
This information is preliminary and will be updated as additional details become available.
CDC is aware of reports of suspected infections among persons who received preservative-free methylprednisolone acetate (MPA) 80mg/mL in 10mL vials produced by the Main Street Family Pharmacy in Newbern, Tennessee. CDC is aware of 20 reported cases from three states – Illinois, North Carolina, and Florida. The majority of these persons developed skin and soft tissue infections of unclear etiology following intramuscular injection of this product. Additional clinical information is being gathered. To date, no reports of meningitis or other life-threatening infections have been reported. All products labeled as sterile have been voluntarily recalled by the pharmacy. CDC is not aware of infections among persons who received products other than preservative-free MPA in the above formulation from this pharmacy. State and local health departments are working with CDC and FDA to evaluate this situation.
*Case Definition: A person who developed a suspected infection associated with injection of a product, labeled as sterile, that was distributed by the Main Street Family Pharmacy (Newbern, TN) since December 1, 2012.
Posted May 30, 2013 5:30 PM ET
This website will be updated on Mondays and Thursdays by 2pm ET.
At a Glance:
Status: On-going Investigation
Reported Cases: 20 *
States reporting cases: 3
Recall: Yes
Initial Announcement
May 30, 2013
Main Street Family Pharmacy in Tennessee: FDA Alerts Health Care Providers of Adverse Reactions Associated with Steroid Injections
State, Federal Health Officials Investigate Reports of Adverse Events among Patients Receiving Methylprednisolone Acetate Injections
Summary of Investigation
This information is preliminary and will be updated as additional details become available.
CDC is aware of reports of suspected infections among persons who received preservative-free methylprednisolone acetate (MPA) 80mg/mL in 10mL vials produced by the Main Street Family Pharmacy in Newbern, Tennessee. CDC is aware of 20 reported cases from three states – Illinois, North Carolina, and Florida. The majority of these persons developed skin and soft tissue infections of unclear etiology following intramuscular injection of this product. Additional clinical information is being gathered. To date, no reports of meningitis or other life-threatening infections have been reported. All products labeled as sterile have been voluntarily recalled by the pharmacy. CDC is not aware of infections among persons who received products other than preservative-free MPA in the above formulation from this pharmacy. State and local health departments are working with CDC and FDA to evaluate this situation.
*Case Definition: A person who developed a suspected infection associated with injection of a product, labeled as sterile, that was distributed by the Main Street Family Pharmacy (Newbern, TN) since December 1, 2012.
Comment